A detailed history of Flower City Capital transactions in Kura Oncology, Inc. stock. As of the latest transaction made, Flower City Capital holds 12,000 shares of KURA stock, worth $74,880. This represents 0.05% of its overall portfolio holdings.

Number of Shares
12,000
Holding current value
$74,880
% of portfolio
0.05%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

Apr 22, 2025

BUY
$6.6 - $9.05 $79,200 - $108,600
12,000 New
12,000 $79,000

Others Institutions Holding KURA

About Kura Oncology, Inc.


  • Ticker KURA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 66,893,000
  • Market Cap $417M
  • Description
  • Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...
More about KURA
Track This Portfolio

Track Flower City Capital Portfolio

Follow Flower City Capital and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Flower City Capital, based on Form 13F filings with the SEC.

News

Stay updated on Flower City Capital with notifications on news.